Back to search
Unresectable Pleural or Peritoneal Malignant Mesothelioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Pleural or Peritoneal Malignant Mesothelioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Unresectable Pleural or Peritoneal Malignant Mesothelioma trials you may qualify forThis example study evaluates locoregional allogeneic dual-target mesothelin/FAP CAR-NK cells in adults with unresectable, recurrent, or refractory pleural or pe…
This is a Phase 1a/1b open-label, dose escalation study to evaluate the safety and efficacy of CT-95 (study drug), a humanized T cell engaging bispecific antibo…
This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of…
This phase I/II trial studies the side effects and the best dose of methoxyamine when given together with cisplatin and pemetrexed disodium and to see how well…
This is a Phase 2b, randomized, double-blind, parallel-group study. Subjects with unresectable pleural or peritoneal malignant mesothelioma will be randomized i…